Report updated May 20, 2026
EMRA Antibiotic Guide
For emergency medicine physicians and residents requiring quick, evidence-based antibiotic guidance during clinical shifts.
EMRA Antibiotic Guide is a struggling reference app that is available. With a 2.7/5 rating from 205 reviews, it struggles with user retention. Users particularly appreciate quick reference tables provide helpful clinical information for daily practice and student study sessions, though app crashes consistently when accessing specific clinical sections like bone and joint on android remains a common concern.
What is EMRA Antibiotic Guide?
EMRA Antibiotic Guide is a clinical reference app for emergency medicine physicians, providing antibiotic dosage and diagnostic recommendations via an annual subscription model.
Clinicians hire this app to reduce cognitive load during high-pressure shifts, but the failure to provide current evidence-based updates undermines the primary job-to-be-done.
Current Momentum
v1.0 · 2mo ago
Zombie- Shipped minor bug fixes.
- Maintained stagnant clinical content.
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Calculates patient-specific antibiotic dosages based on clinical inputs
Universal search interface for rapid navigation of antibiotic recommendations
How much does it cost?
- Annual subscription at $9.99 USD per year
Subscription-only model anchored at $9.99/year, requiring payment for all content access with no free trial.
Who Built It?
Equipping emergency medicine residents with evidence-based clinical decision support tools for rapid point-of-care reference.
Portfolio
4
Apps
What other apps does Emergency Medicine Residents' Association make?
Explore the full Emergency Medicine Residents' Association report
Portfolio breakdown, audience, momentum, and every app published by Emergency Medicine Residents' Association.
What do users think recently?
High confidence · 84 reviews analyzed · Based on 84 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate quick reference tables provide helpful clinical information for daily practice and student study sessions, but report app crashes consistently when accessing specific clinical sections like bone and joint on android and subscription management and account restoration fail when users upgrade to new mobile devices.
What Users Love
What Frustrates Users
What Users Want
How have ratings & review volume moved?
Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.
Vertical markers = app releases. Hover any release for the post-release impact delta.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for EMRA Antibiotic Guide?
How's The Reference Market?
How does it evolve in the Reference market?
The app holds the #80 Grossing position in the US Medical category, but the 2.43 Android rating indicates significant friction compared to the category average. This performance gap suggests that technical instability is actively suppressing monetization potential.
Rank progression
11 active rankings tracked — 30-day window
The rivals identified
Nemeses(1)
As a government-backed clinical decision support tool, it competes directly for the attention of clinicians seeking authoritative, evidence-based vaccination and antibiotic guidance during patient encounters.
Contenders(4)
This app is a direct competitor for the 'on-shift' reference market, offering rapid clinical knowledge and decision support tools.
It overlaps with the target app by providing essential clinical interpretation data that clinicians need to make informed prescribing decisions.
It serves as a comprehensive medical reference library, competing with the target app for users seeking quick, reliable clinical information.
This app competes for the same emergency medicine audience by providing standardized, high-stakes clinical algorithms and protocol-based decision support.
Same space(3)
It competes for the medical professional's attention by providing emergency notification and patient monitoring capabilities.
It provides clinical reference and reporting tools that overlap with the target app's goal of supporting efficient medical practice.
It targets the same emergency medicine clinicians by providing essential timing tools for high-acuity code situations.
Compare EMRA Antibiotic Guide against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for EMRA Antibiotic Guide
Strengths to defend, gaps to attack
Core Strengths
- Emergency-specific workflow integration
- Evidence-based Choosing Wisely guideline support
- Professional association branding
Critical Frictions
- 2.43 Android rating
- Critical subscription restoration failures
- Stagnant clinical content updates
Growth Levers
- Wearable clinical support integration
- Electronic health record connectivity
- Residency program B2B partnerships
Market Threats
- UpToDate institutional dominance
- Free Merck Manual alternatives
- Declining user trust from crash bugs
What are the next best moves?
Rebuild subscription restoration flow because users cannot access paid content after device upgrades → reduce refund surge
Subscription management failure is a top-cited complaint theme.
Trade-off: Pause the planned UI refresh for the search interface — restoration is a revenue-blocker.
Audit Android crash logs in orthopedic sections because multiple users report immediate shutdowns → improve retention
High-frequency crash reports on Android are driving the 2.43 rating.
Trade-off: Delay the pediatric dosage calculator update — stability is the current churn driver.
A counter-intuitive read
The app's subscription-only model is not a revenue driver but a churn accelerator, as the lack of a free trial prevents users from verifying the app's current content accuracy.
Feature Gaps vs Competitors
- Real-time clinical decision support (available in Johns Hopkins Antibiotic Guide but absent here)
Key Takeaways
The app provides essential clinical utility but is failing to maintain basic technical reliability, so the PM must prioritize fixing subscription restoration and crash bugs to prevent total user churn.
Where Is It Heading?
Declining
The clinical reference market is consolidating around high-velocity, evidence-based tools that integrate into institutional workflows. EMRA's current maintenance-mode posture leaves it exposed to competitors that offer superior reliability and content freshness, so the app's survival depends on immediate technical remediation.
Persistent crash reports on Android sections erode the daily active habit, which compounds the rating drag already visible on the platform.
Stagnant clinical content updates despite annual billing drive user frustration, accelerating churn pressure toward free alternatives like Merck Manual.